Literature DB >> 11083251

Intradevice interaction in a dual chamber implantable cardioverter defibrillator preventing ventricular tachyarrhythmia detection.

K Shivkumar1, Z Feliciano, N G Boyle, I Wiener.   

Abstract

Failure to detect ventricular tachycardia and/or ventricular fibrillation by implantable cardioverter defibrillators (ICDs) is a rare but serious problem. We report a case of failure to detect an episode of induced ventricular tachycardia by a dual chamber ICD, due to abbreviation of ventricular detection window secondary to programmed pacing parameters and a rate-smoothing algorithm. In this patient, the intradevice interaction was corrected by programming rate-smoothing off. This report highlights the potentially lethal consequences of critical timing relationships among the pacing function, arrhythmia detection, and the characteristics of the arrhythmia when using a modern dual chamber ICD. Physicians responsible for patients with ICDs must be aware of such interactions.

Entities:  

Mesh:

Year:  2000        PMID: 11083251     DOI: 10.1046/j.1540-8167.2000.01285.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  5 in total

1.  Case report: Delayed detection of ventricular tachycardia due to intradevice interactions by implantable atrio-ventricular pacer/cardioverter defibrillator.

Authors:  Bharat K Kantharia; Farooq A Padder
Journal:  J Interv Card Electrophysiol       Date:  2006-10-03       Impact factor: 1.900

Review 2.  Algorithms for better arrhythmia discrimination in implantable cardioverter defibrillators.

Authors:  R Schimpf; C Wolpert; B Lüderitz
Journal:  Curr Cardiol Rep       Date:  2001-11       Impact factor: 2.931

Review 3.  Should all implantable cardioverter defibrillators for ventricular arrhythmias be dual-chamber devices?

Authors:  K L Lee; C P Lau
Journal:  Curr Cardiol Rep       Date:  2001-11       Impact factor: 2.931

4.  Very Low Ventricular Pacing Rates Can Be Achieved Safely in a Heterogeneous Pacemaker Population and Provide Clinical Benefits: The CANadian Multi-Centre Randomised Study-Spontaneous AtrioVEntricular Conduction pReservation (CAN-SAVE R) Trial.

Authors:  Bernard Thibault; Anique Ducharme; Adrian Baranchuk; Marc Dubuc; Katia Dyrda; Peter G Guerra; Laurent Macle; Blandine Mondésert; Léna Rivard; Denis Roy; Mario Talajic; Jason Andrade; Rémi Nitzsché; Paul Khairy
Journal:  J Am Heart Assoc       Date:  2015-07-23       Impact factor: 5.501

5.  Masked premature ventricular contractions and intradevice interaction causing ventricular fibrillation.

Authors:  Duc H Do; Scott Meyer; Jason Bradfield; Kalyanam Shivkumar; Noel G Boyle; Houman Khakpour
Journal:  HeartRhythm Case Rep       Date:  2020-11-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.